138 results on '"Kammala, Ananth Kumar"'
Search Results
2. PGRMC2 and HLA-G regulate immune homeostasis in a microphysiological model of human maternal-fetal membrane interface
3. Placental alkaline phosphatase (PLAP): Is it exclusively placental?
4. A multi-organ, feto-maternal interface organ-on-chip, models pregnancy pathology and is a useful preclinical extracellular vesicle drug trial platform
5. Exosomal delivery of IL-10: Biodistribution, pharmacokinetics, and preterm birth prevention strategies
6. Cytochrome P450-mediated alterations in clinical pharmacokinetic parameters of conventional drugs coadministered with piperine: a systematic review and meta-analysis
7. Fetal membranes exhibit similar nutrient transporter expression profiles to the placenta
8. Expression of CYP450 enzymes in human fetal membranes and its implications in xenobiotic metabolism during pregnancy
9. New approach methods on the bench side to accelerate clinical trials during pregnancy
10. In vitro mRNA‐S maternal vaccination induced altered immune regulation at the maternal‐fetal interface
11. Aspartame Causes Developmental Defects and Teratogenicity in Zebra Fish Embryo: Role of Impaired SIRT1/FOXO3a Axis in Neuron Cells
12. Extracellular vesicles from maternal uterine cells exposed to risk factors cause fetal inflammatory response
13. Are fetal microchimerism and circulating fetal extracellular vesicles important links between spontaneous preterm delivery and maternal cardiovascular disease risk?
14. Autophagy Determines Distinct Cell Fates in Human Amnion and Chorion Cells
15. 402 Chorion-Derived Extracellular Vesicles Cargo Transporter protein BCRP: Paracrine drug transportation at the feto-maternal interface
16. 627 Does the dosing of low-dose aspirin for preeclampsia prevention alter serum extracellular vesicle characteristics?
17. 305 A multi-organ fetal membrane-placenta-on-chip platform to study the transmission of infection and inflammation during pregnancy
18. 317 A 3D printed device for electrophysiological measurement of myometrial smooth muscle cell contractions in vitro
19. 306 A multi-organ-on-chip model to study the efficacy of exosomal therapeutics in treating inflammation-associated adverse pregnancies
20. 767 Differential Packaging of Nuclear and Membrane Progesterone Receptors in Myometrial and Decidual Cell Exosomes
21. 626 Extracellular Vesicles Carrying Efflux Protein P-glycoprotein Alter Drug Transport Functions in Decidua
22. High-Throughput 3D-Printed Model of the Feto-Maternal Interface for the Discovery and Development of Preterm Birth Therapies.
23. Characterization of fetal microchimeric immune cells in mouse maternal hearts during physiologic and pathologic pregnancies
24. Extracellular Vesicles-mediated recombinant IL-10 protects against ascending infection-associated preterm birth by reducing fetal inflammatory response
25. Development of oxidative stress‐associated disease models using feto‐maternal interface organ‐on‐a‐chip
26. Bromo-protopine, a novel protopine derivative, alleviates tau pathology by activating chaperone-mediated autophagy for Alzheimer’s disease therapy
27. Modeling ascending Ureaplasma parvum infection through the female reproductive tract using vagina‐cervix‐decidua‐organ‐on‐a‐chip and feto‐maternal interface‐organ‐on‐a‐chip
28. Extracellular Vesicles-mediated recombinant IL-10 protects against ascending infectionassociated preterm birth by reducing fetal inflammatory response.
29. Exosomes from Ureaplasma parvum-infected ectocervical epithelial cells promote feto-maternal interface inflammation but are insufficient to cause preterm delivery
30. Computational Screening of the Natural Product Osthole and Its Derivates for Anti-Inflammatory Activity
31. Computer Aided Drug Design Approach to Screen Phytoconstituents of Adhatoda vasica as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme
32. Novel Bench-To-Bedside Tools: Feto-Maternal Interface Organ-On-Chip’s
33. Testing Pharmacokinetics and Efficacy of Pravastatin Using Feto-Maternal Interface Organ-On-Chips
34. Development of physiologically based pharmacokinetic model using artificial intelligence based approaches for pravastatin during pregnancy
35. Cervix-on-a-chip for investigating ascending Ureaplasma parvum infection in pregnancy
36. Fetal membrane cells contribute to drug transportation across the maternal-fetal interface
37. Organic Anion Transporting Polypeptide 2B1 in Human Fetal Membranes: A Novel Gatekeeper for Drug Transport During Pregnancy?
38. Development of a mouse model of ascending infection and preterm birth
39. Extracellular Vesicles from Maternal Uterine Cells Exposed to Risk Factors cause Fetal Inflammatory Response
40. Microvesicles and exosomes released by amnion epithelial cells under oxidative stress cause inflammatory changes in uterine cells†
41. Ruxolitinib ameliorates airway hyper responsiveness and lung inflammation in a corticosteroid-resistant murine model of severe asthma
42. G-protein coupled receptor kinase 2 (GRK2) regulates T cell response in a murine model of house dust mite-induced asthma
43. Na+/H+ exchanger regulatory factor 1 (NHERF1) enhances MRGPRX2-mediated mast cell anaphylaxis
44. Evaluation of Plasma Level of Heme-Oxygenase-1 in Neonatal Hypoxic Ischemic Encephalopathy.
45. 13 Development of an Ascending Model of Infection and Preterm Birth
46. Sodium Hydrogen Exchanger Regulatory Factor-1 (NHERF1) Regulates Fetal Membrane Inflammation
47. A novel role for the adapter molecule NHERF1 in regulating mast cell-mediated anaphylaxis
48. STIM1 contributes to mast cell functional response via MrgprX2
49. Structural Elucidation of Possible Metabolic Profile of Mangiferin by Oral and Intraperitoneal Administration
50. How can we advance drug delivery options using extracellular vesicles for pregnant women to reduce preterm birth?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.